Clinical trial
A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma
NCT00241371 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma
- Lead sponsor
- Washington University School of Medicine
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 31, 2005
- Completion date
- December 31, 2007
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.